Back to top

Protagonist Therapeutics Stockholders Approve Key Proposals

Protagonist Therapeutics ( ($PTGX) ) has provided an update. At the Annual Meeting, Protagonist Therapeutics‘ stockholders voted on three key propo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Invesco Financial Preferred ETF (PGF)

Protagonist Therapeutics, Inc. (PTGX)